This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 7 verdict, jurors assessed punitive damages totaling
$6 billion against Actos manufacturer Takeda Pharmaceutical Co. Ltd. of
Osaka, Japan, and
$3 billion against
Indianapolis-based Eli Lilly & Co. (NYSE:LLY), which marketed the drug in the U.S. from its debut in 1999 to 2006. Actos generated more than
$16 billion in sales since its release.
Trial evidence showed that experts warned of Actos' link to bladder cancer a full seven years before Takeda issued related warnings to patients. Mr. Allen began taking the medication in 2006 and was diagnosed with bladder cancer in 2011.
"Eight people from
Lafayette, Louisiana, spoke loudly about how business is to be conducted in America," says Mr. Lanier. "This should be a wake-up call to any business that acts with reckless disregard for the safety of people."
Mr. Lanier and the other attorneys who won the
$9 billion verdict on behalf of the Allen family also represent clients in many of the additional Actos cases that are currently pending. More than 2,700 Actos lawsuits have been consolidated in Judge Doherty's federal court, and Takeda and Eli Lilly face hundreds of state court claims throughout the U.S.
With offices in
Los Angeles, and
New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of
outstanding trial attorneys with decades of experience handling cases involving
maritime law, and
sports and entertainment law.
For more information on the Actos verdict or to speak with Mr. Lanier, please contact J.D. Cargill at 713-659-5200.